Percutaneous Tricuspid Valve Implantation (PTVI)

Andreas Eicken, Peter Ewert

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Surgical tricuspid valve replacement is performed in a small number of patients with congenital heart disease, in whom a surgical valve plasty has failed. Usually, in tricuspid position, a biological valve prosthesis is chosen. These bioprosthesis undergo natural degeneration. Percutaneous tricuspid valve implantation (PTVI) is an off-label catheter intervention, which may enhance the life span of a bioprosthesis in tricuspid position and, hence, reduce the total number of heart surgeries in a patient’s life.

Original languageEnglish
Title of host publicationCardiac Catheterization for Congenital Heart Disease
Subtitle of host publicationFrom Fetal Life to Adulthood, Second Edition
PublisherSpringer International Publishing
Pages769-781
Number of pages13
ISBN (Electronic)9783030698560
ISBN (Print)9783030698553
DOIs
StatePublished - 1 Jan 2021

Keywords

  • Bioprosthesis
  • Catheter intervention
  • Percutaneous tricuspid valve implantation
  • Tricuspid valve replacement

Fingerprint

Dive into the research topics of 'Percutaneous Tricuspid Valve Implantation (PTVI)'. Together they form a unique fingerprint.

Cite this